Comparison of the binding kinetics of antibody-targeted N-(2-hydroxypropyl) methacrylamide (HPMA)-bound doxorubicin in vitro and in vivo

Journal of Controlled Release

Volumn 42, Issue 3, 1996, Pages 229-236

  Št'astný, Marek ^a   Říhová, Blanka ^a   Strohalm, Jiří ^b   Ulbrich, Karel ^b  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

Author keywords

Antibody targeted drugs; Doxorubicin; Flow cytometry; HPMA based polymeric carrier; Pharmacokinetics

Indexed keywords

ANTIBODY CONJUGATE; DOXORUBICIN; N (2 HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER; OKT 4; PRODRUG; THY 1 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG TARGETING; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; IMMUNOFLUORESCENCE; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; THYMOCYTE;

EID: 0030560836     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(96)01463-0     Document Type: Article

References (23)

1. [1] P. Ehrlich, Studies in Immunity, Plenum Press, N.Y., 1906.
2. [2] R.W. Baldwin, V.S. Byers and R.D. Mann (Eds.), Monoclonal antibodies and immunoconjugates, Carnforth: Parthenon Publishing, 1990.
3. [3] A. Rahman and P.S. Schein, Liposomes as a drug carriers, Gregoriadis G. (Ed.), New York: John Wiley, 1988, 381-400.
4. [4] P. Couvreur, L. Roblot-Treupel and M.F. Poupon, Nanoparticles as microcarriers for anticancer drugs, Adv. Drug Deliv. Rev. 5 (1990) 209-230.
5. [5] J. Kopeček, P. Rejmanová, J. Strohalm, K. Ulbrich, B. Říhová, V. Chytrý, R. Duncan and J.B. Lloyd, Czechoslovak. Pat. Appl. PV 97-85, Jan. 4, (1985).
6. [6] P. Rejmanová, J. Kopeček, R. Duncan and J.B. Lloyd, Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in HPMA copolymers, Biomaterials 6 (1985) 45-48.
7. [7] V. Šubr, J. Kopeček, J. Pohl, M. Baudyš and V. Kostka, Cleavage of oligopeptide side chains in HPMA copolymers by mixtures of lysosomal enzymes, J. Control. Release 8 (1988) 133-140.
8. [8] B. Říhová and J. Kopeček, Biological properties of targetable poly N-(2-hydroxypropyl) methacrylamide - antibody conjugates. J Control. Release 2 (1985) 289.
9. [9] B. Říhová, A. Jegorov, J. Strohalm, J. Mat'ha, P. Rossmann, L. Fornůsek and K. Ulbrich, Antibody-targeted CsA, J. Control. Release 19 (1992) 25-39.
10. [10] B. Říhová, P. Kopečková, J. Strohalm, P. Rossmann, V. Větvička and J. Kopeček, Antibody directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of DNM conjugated to HPMA copolymers and targeting antibody, Clin. Immunol. Immunopathol. 46 (1988) 100-114.
11. [11] B. Říhová, J. Kopeček, K. Ulbrich and J. Chytrý, Immunogenicity of N-(2-hydroxypropyl) methacrylamide copolymers, Macromol. Chem. Suppl. 9 (1985) 13-24.
12. [12] R.H. Levey and P.B. Medawar, Some experiments on the action of antilymphoid antisera, Ann. N.Y. Acad. Sci. 120 (1966) 164-177.
13. [13] Current Protocols in Immunology 1992, John Wiley (Ed.), Immunofluorescence and Cell Sorting: unit 5.3 (1992).
14. 135I/ daunomycin, J. Control. Release 10 (1989) 37-49.
15. [15] P. Rejmanová, J. Labský and J. Kopeček, Aminolysis of monomeric and polymeric p-nitrophenyl esters of methacryloylated amino acids, Macromol. Chem. 178 (1977) 2159-2168.
16. [16] J. Kopeček, Synthesis of tailor-made soluble polymeric drug earners, In: J.M. Anderson and S.W. Kim (Eds.), Recent Advances in Drug Delivery Systems, Plenum Press, New York, NY, 1984, pp. 41-62.
17. [17] B. Říhová, J. Strohahn, D. Plocová and K. Ulbrich, Selectivity of antibody-targeted anthracykline antibiotics on T-lymphocytes. J. Bioact. Compat. Polym. 5 (1990) 249-266.
18. [18] R.L. Boyd and P. Hugo, Towards an integrated view of thymopoiesis, Immunol. Today 12/2 (1991) 71-74.
19. [19] H. von Boehmer, Thymic selection: a matter of live and death, Immunol. Today 13/11 (1992) 454-458.
20. [20] P. Nieuwenhuis, R.J.M. Stet, J.P.A. Wagenaar, A.S. Wubbena, J. Kampinga and A. Karrenbeld. The transcapsular route: a new way for (self-) antigens to by-pass the blood-thymus barrier? Immunol. Today 9/12 (1988) 372-375.
21. [21] B. Říhová, M. Bilej, V. Větvička, K. Ulbrich, J. Strohalm, J. Kopeček and R. Duncan, Biocompatibility of N-(2-hydroxypropyl)methacrylamtde copolymers containing adriamycin, Biomaterials 10 (1989) 335-342.
22. [22] R. Duncan, P. Kopečková-Rejmanová, J. Strohalm, I. Hume, H.C. Cable, J. Pohl, J.B. Lloyd and J. Kopeček, Anticancer agents coupled to N-(2-hydroxypropyl) methacrylamide copolymers. Evaluation of daunomycin and puromycin conjugates in vitro, Br. J. Cancer 55 (1987) 165-174.
23. [23] R. Duncan, L.W. Seymour, K.B. O'Hare, K. Ulbrich, Pre-clinical evaluation of polymer-bound DOX, J. Control. Release 19 (1992) 331-346.